Nature Communications (Sep 2018)

Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome

  • Michael Rusch,
  • Joy Nakitandwe,
  • Sheila Shurtleff,
  • Scott Newman,
  • Zhaojie Zhang,
  • Michael N. Edmonson,
  • Matthew Parker,
  • Yuannian Jiao,
  • Xiaotu Ma,
  • Yanling Liu,
  • Jiali Gu,
  • Michael F. Walsh,
  • Jared Becksfort,
  • Andrew Thrasher,
  • Yongjin Li,
  • James McMurry,
  • Erin Hedlund,
  • Aman Patel,
  • John Easton,
  • Donald Yergeau,
  • Bhavin Vadodaria,
  • Ruth G. Tatevossian,
  • Susana Raimondi,
  • Dale Hedges,
  • Xiang Chen,
  • Kohei Hagiwara,
  • Rose McGee,
  • Giles W. Robinson,
  • Jeffery M. Klco,
  • Tanja A. Gruber,
  • David W. Ellison,
  • James R Downing,
  • Jinghui Zhang

DOI
https://doi.org/10.1038/s41467-018-06485-7
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 13

Abstract

Read online

Clinical oncology is rapidly adopting next-generation sequencing technology for nucleotide variant and indel detection. Here the authors present a three-platform approach (whole-genome, whole-exome, and whole-transcriptome) in pediatric patients for the detection of diverse types of germline and somatic variants.